HLB Pharmaceutical Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2019	FY 2018	FY 2017
Period Ending	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Net Income	472.65	-7,060	-5,447
Depreciation & Amortization	1,640	1,143	1,055
Loss (Gain) From Sale of Assets	2.08	31.53	0.62
Asset Writedown & Restructuring Costs	438.73	-	509.63
Loss (Gain) From Sale of Investments	-120.89	-164.96	137.71
Stock-Based Compensation	105.02	431.59	454.54
Provision & Write-off of Bad Debts	124.02	16.52	-40.69
Other Operating Activities	943.5	2,269	2,425
Change in Accounts Receivable	-1,990	1,253	2,198
Change in Inventory	-266.03	-397.13	-2,194
Change in Accounts Payable	-2,452	946.47	-253.52
Change in Other Net Operating Assets	2,456	-246.42	370.51
Operating Cash Flow	1,353	-1,777	-784.3
Capital Expenditures	-1,397	-1,095	-2,236
Sale of Property, Plant & Equipment	4	24.01	3.4
Divestitures	-	937.48	-
Sale (Purchase) of Intangibles	-540.15	-280.15	-192.6
Investment in Securities	-5,058	617.85	3,559
Other Investing Activities	43.27	105	37.98
Investing Cash Flow	-6,938	309.09	1,172
Short-Term Debt Issued	1,892	-	1,725
Long-Term Debt Issued	10,914	-	1,400
Total Debt Issued	12,806	-	3,125
Short-Term Debt Repaid	-5,546	-371.25	-1,400
Long-Term Debt Repaid	-1,961	-480	-580
Total Debt Repaid	-7,507	-851.25	-1,980
Net Debt Issued (Repaid)	5,299	-851.25	1,145
Financing Cash Flow	5,299	-851.25	1,145
Foreign Exchange Rate Adjustments	-	-0.35	3,833
Net Cash Flow	-286.08	-2,320	5,365
Free Cash Flow	-43.8	-2,872	-3,020
Free Cash Flow Margin	-0.12%	-13.98%	-19.41%
Free Cash Flow Per Share	-3.16	-212.19	-252.31
Cash Interest Paid	288.41	207.01	274.48
Cash Income Tax Paid	58.82	17.4	4.95
Levered Free Cash Flow	1,808	-540.14	-
Unlevered Free Cash Flow	2,554	-2.9	-
Change in Working Capital	-2,252	1,556	120.3

Source: S&P Capital IQ. Standard template. Financial Sources.